Air pollution may affect lupus risk
New research published in Arthritis & Rheumatology indicates that chronic exposure to air pollutants may increase the risk of developing lupus, an autoimmune disease that affects multiple organs.
Inmunología
Stem cell-derived therapy shows promise against treatment-resistant liver cancer
Researchers at University of California San Diego have found that the most common form of liver cancer—one with a high mortality rate—can be better targeted and treated using an innovative new stem cell-derived therapy, according to a recently publishe…
Inulin-gel-based oral immunotherapy may offer long-awaited treatment for food allergy sufferers
A study from the University of Michigan has identified a potential new treatment for food allergies in inulin, a naturally occurring plant fiber commonly used as a supplement, a prebiotic in soda, a replacement for sweeteners and for other products and…
Q&A: New strategy can improve cell therapy against cancer
Researchers at the Center for Infectious Medicine at the Department of Medicine, Huddinge have developed a new strategy that can make cell therapy against cancer work longer in patients. The results are published in the journal Cell Stem Cell.
Hepatitis C leaves ‘scars’ in immune cells even after successful treatment
Chronic hepatitis C, caused by the hepatitis C virus, can lead to severe complications such as liver cirrhosis and liver cancer. The advent of highly effective direct-acting antivirals (DAAs) has resulted in high cure rates for this chronic viral infec…
Small molecules induce trained immunity, opening a new approach to fighting disease
Vaccines provide a front-line defense against dangerous viruses, training adaptive immune cells to identify and fight specific pathogens.
Researchers find a common immune system mechanism between pregnancy and cancer
To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy.
Study highlights the importance of infection prevention after CAR T-cell therapy
Researchers at Dana-Farber Cancer Institute, in collaboration with colleagues from Memorial Sloan Kettering Cancer Center in New York (Dr. Kai Rejeski) and the LMU Hospital in Munich, Germany (Dr. Tobias Tix), have found that infections were the main d…
Scientists discover how to improve vaccine response to potentially deadly bacterium
Researchers from Trinity College Dublin have taken a leap forward in understanding how we might fight back against the potentially deadly MRSA bacterium. They have shown in an animal model that targeting a key suppressive immune molecule (IL-10) during…
World’s first CAR-T cell therapy for a child with lupus
In June 2023, Uresa A. (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which is a serious autoimmune disease that was attacking…